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Received June 18, 2001Is Anguilla anguilla L. (eel) liver ethoxyresoru5n O-
deethylase (EROD) induction absolutely necessary in order to
convert promutagens as benzo[a]pyrene (BaP) into a mutagenic
compound? Eels were exposed for 8 h to clean (control) and
0.3 M -naphtho6avone (BNF)-contaminated water. The 8-h
exposure to 0.3 M BNF brought about a very high EROD
induction (10 pmol/min/mg protein) compared to control ani-
mals (1 pmol/min/mg protein). The Ames test (Maron and
Ames, 1983) was carried out with Salmonella typhimurium TA
98 strain (TA98 His) and eel isolated S9 liver fraction was used
as a metabolic BaP activator. The BaP and BNF dose range
concentrations tested were 0 (blank), 0.015, 0.08, 0.15, 0.38, 0.75,
1.5, 3.8, and 7.5 M/plate and 0 (blank), 0.412, 1.235, 3.704,
11.1, 33.0, and 100 nM BNF, respectively. A dose+response
relationship between BaP concentration and mutagenic activity
was observed in the presence of S9 fractions in control and 0.3
M BNF-exposed eels. Signi5cant positive results, as TA98
His revertants, were observed at 0.38, 0.75, 1.5, 3.8, and 7.5 M
BaP/plate induced by BNF S9 fractions. Signi5cant BaP
mutagenic activation by liver control S9 was detected only at 1.5,
3.8, and 7.5 M/plate. The BaP 1.5, 3.8, and 7.5 M/plate
mutagenic activation by BNF S9 and control S9 were not signi5-
cantly di4erent. Relative to BNF activation, it was only possible to
detect His reversion at 11.1 nM BNF concentration with 0.3 M
BNF-induced S9. The above results demonstrate that the eel S9
liver fraction has the capacity to biotransform high BaP concen-
trations and convert it into a mutagenic compound with or without
previous liver BNF biotransformation induction. The same does
not apply to low BaP concentrations, where liver S9 induction by
BNF is necessary to promote mutagenesis.  2002 Elsevier Science (USA)
Key Words: mutagenesis; Ames test; Fish liver s9; BaP; BNF;
EROD; Anguilla anguilla L.
INTRODUCTION
A wide range of chemicals, such as polycyclic aromatic
hydrocarbons (PAHs), require bioactivation bymicrosomal orTo whom correspondence should be addressed. E-mail: monteiro@
bio.ua.pt.
8cytosolic enzymes to produce mutagenic e!ects (Stegeman,
1981; Buhler and Williams, 1988,1989; LoH pez-Barea
and Pueyo, 1998; Fourman, 1989). Since many of these
catalysts are induced by environmental pollutants, an in-
creased activation of promutagens is used to monitor pollu-
tion. The S9-activating capacity of several contaminants
into mutagens which are detectable by bacterial genotoxic-
ity assays has been validated in "sh. Another detection
method is the biotransforming activity of several di!erent
enzymes. These tests can be used as powerful biomarkers
in "eld environment studies or in exposure studies with
model compounds (RodrmHguez-Ariza et al., 1994, 1995;
DmHaz-MeH ndez et al., 1998).
PAH compounds frequently found in the environment
have been associated with areas that demonstrate high
tumor prevalence in "sh populations (Baumann, 1984;
Black, 1983; Malins et al., 1987). The mutagenicity of these
compounds is a well-known consequence of their metabolic
activation (Thakker et al., 1985).
Benzo[a]pyrene (BaP), a model PAH compound, is clas-
si"ed as a promutagen, i.e., chemical substance that must be
metabolically activated to become a DNA-damaging agent
(Johnson, 1992). It is regarded as a clastogen and a potent
animal carcinogen (Vainio et al., 1985; Varanasi, 1987;
Hawkins et al., 1990). BaP must be activated and/or alterna-
tively detoxi"ed by metabolically favored pathways. The
above "ndings suggest the need for a balance between the
Phase I and Phase II detoxi"cation process. Other compounds
such as -naphtho#avone (BNF) a (PAH-like compound)
are strong ethoxyresoru"n O-deethylase (EROD) inducers
(Pacheco and Santos, 1998, Schlezinger and Stegeman,
2000). This synthetic #avonoid compound produces e!ects
on the microsomal cytochrome P-450 (P450)-dependent
monooxygenase system, which is involved in the metabolic
activation and detoxi"cation of a wide range of procar-
cinogenic contaminants (Wiebel, 1980).
A number of "sh studies on the genotoxic e!ects of BaP
and/or BNF have been performed using cytogenetic tests,
such as the presence of micronuclei (Grinfeld et al., 1986),1
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82 MARIA, CORREIA, AND SANTOSerythrocytic nuclear abnormalities (ENA) (Pacheco and
Santos, 1997, 1998), chromosome aberrations (Hoofman,
1981), and tumor detection (Hendricks et al., 1985, Hawkins
et al., 1988).
The capability of hepatic S9 fractions to activate known
promutagens provides a better evaluation of xenobiotic
metabolism than the determination of liver biotransforma-
tion enzymes. The Salmonella/microsome test has been used
by Ames et al. (1975) and Paolini et al. (1991) to assess the
potentially mutagenic and carcinogenic intermediate
metabolites resulting from xenobiotic biotransformation.
The adaptation of "sh liver homogenates to the
Salmonella/microsome (Kurelec et al., 1979; RodrmHguez-
Ariza et al., 1995) and SOS-umu tests (Bihari et al., 1990) has
been reported, although not yet extensively characterized.
Previous research studies have reported metabolic activa-
tion of BaP by liver S9 fractions of Mugil sp. (grey mullet)
from contaminated environments (RodrmHguez-Ariza et al.,
1994) and carp under laboratory experimental conditions
(Britvic and Kurelec, 1986). The mutagenic potential of BaP
and BNF on European eel (Anguilla anguilla L.) has not
been su$ciently investigated, because it is a migrant "sh
which may have been exposed to a wide range of potentially
genotoxic environmental contaminants. Pacheco and
Santos (1997, 1998, 2002) have demonstrated that eel is
a good model species for genotoxicity screening as well as
for liver function response studies on PAHs and PAH-like
compounds. In this perspective, the purpose of the current
study was to determine whether pre-induction of EROD in
eel liver is necessary for conversion of a promutagen into
a mutagenic compound.
MATERIALS AND METHODS
Chemicals
BNF, BaP, and dimethyl sulfoxide (DMSO) were ob-
tained from Sigma Chemical Co. (St. Louis, MO). All chem-
icals used were of analytical grade and were purchased
from Sigma, Boehringer Mannheim GmbH (Germany), or
E. Merck-Darmstadt (Germany).
Test Animals
The experiment was carried out on A. anguilla L. (eel),
average weight 50 g, collected from the Aveiro lagoon. The
eels were transported under anoxic conditions and ac-
climated to laboratory conditions in aerated, "ltered, and
dechlorinated tap water in 200-L aquaria for 1 week, at
203C. Eels were exposed for 8 h to 0 (control) and 0.3 M
BNF. Control "sh were exposed to DMSO. Two tanks
containing 20 animals each were used for control and BNF
exposure. Fish were killed by decapitation and livers were
sampled, immediately frozen in liquid nitrogen, and stored
at!203C until homogenization.Preparation of Liver Postmitochondrial Supernatant (S9)
and S9 Mixture
The liver S9 fraction is based on the procedure of Maron
and Ames (1983). All steps of the procedure are carried out
at 0}43C using cold, sterile solutions and glassware. Livers
were homogenized with three volumes of 0.15M KCl in
a Potter}Elvehjem apparatus with a Te#on pestle and the
homogenates centrifuged at 9000 g for 10min. Supernatants
(S9 fractions) were decanted, avoiding the super"cial lipid
layer. The freshly prepared S9 fractions were distributed
(1 to 2-ml portions) in small sterile polystyrene tubes and
immediately stored at!803C.
The S9 mixture contained 5 mM glucose-6-phosphate,
4 mMNADP, 8 mMMgCl

, 33 mMKCl, 100 mM sodium
phosphate bu!er (pH 7.4), and 50 l of the S9 fraction, in
0.5ml total volume. This mixture was prepared immediately
before each experiment and maintained at 43C.
Bacterial Strain
Salmonella typhimurium TA98 strain was used as an
indicator of genotoxic activity. The bacteria carrying
the his auxothrophy (hisD3052) required for the His
assay contain the R-factor plasmid pKM101 and two
mutations, rfa and uvrb. This strain was kindly provided by
Dr. B. N. Ames, University of California, Berkley. The
test strain genotypes were con"rmed for each mutagenicity
assay.
Mutagenicity and Metabolic Activation Assays
Mutagenicity and metabolic activation were performed
using the Ames method (Maron and Ames, 1983). The assay
was carried out in the absence and in the presence of the S9
mixtures from BNF-induced and uninduced eel liver. Three
independent experiments were performed and duplicates
were used for each tested dose. A bacterial suspension of
0.1ml (14 h overnight culture in nutrient broth (NB)
from Oxoid, approximate density 1}210 cells/ml) was
pipetted into molten top agar. BaP doses and BNF concen-
trations used were 0 (blank), 0.015, 0.08, 0.15, 0.38,
0.75, 1.5, 3.8, and 7.5 M/plate, and 0.412, 1.235,
3.704, 11.1, 33.0, and 100 nM, respectively. The BaP and
BNF samples were dissolved in DMSO. BaP, BNF,
biotin, L-histidine, NaCl, and 0.5ml of S9 mixture were
added to top agar, poured into plates containing
minimal medium, and incubated 48 h at 373C. After incuba-
tion, the number of histidine-independent revertants was
counted. For a response to be considered positive the num-
ber of revertants has to double the number of spontaneous
revertants (blank plates) and a clear relationship between
mutagenic response and dose of mutagen or amount of S9
had to be observed.
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FIG.2. Increasing doses of BNF (nM/plate) were assayed with 10
bacteria (TA 98) and 50 L of liver S9. Assays without S9 (!S9) were
included as controls. Data indicate the total number of His revertants per
plate, plotted as mean$SE of two replicates of three independent experi-
ments. S9I, S9 fraction BNF-induced; S9NI, S9 fraction noninduced.
TABLE 1
Benzo[a]pyrene (BaP) Mutagenic Activation
by Anguilla anguilla L. Liver S9 Fraction
#S9
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The results are expressed as means$standard error (SE)
and statistical analysis was performed using a two-tailed
Student t test (Bailey, 1959).
RESULTS
Eels Exposure to BNF
The eel liver EROD response was signi"cantly increased
after 8 h exposure to 0.3 M BNF (P(0.01) compared to
control level. Liver P450 was not signi"cantly di!erent from
control.
Mutagenic Response of the His Reverse Mutation Assay
in Bacterial Strain TA98
The number of S. typhimurium TA98 strain His rever-
tants per selective plate, respectively, induced by increasing
doses of BaP (M/plate) 0, 0.015, 0.08, 0.15, 0.38, 0.75, 1.5,
3.8, and 7.5 (Fig. 1) and BNF (nM/plate) 0.412, 1.235, 3.704,
11.1, 33, and 100 nM (Fig. 2), was counted and expressed as
means$SE of two replicates in three independent experi-
ments.
As seen in Fig. 1 and Table 1, there was a dose}response
relationship between BaP dose and the number of His
revertants in eel BNF-induced and noninduced liver S9.
BNF-induced S9 had an increased number of His rever-
tants in the 0.38, 0.75, 1.5, 3.8, and 7.5 M BaP/plate doses,
demonstrating its activation into a genotoxic compound.
Induction potential, expressed as the ratio of BaP concen-
tration to the number of blank revertants (without BaP,
spontaneous revertants) was 2.2-, 2.8-, 3.2-, 3.6-, and 4.3-
fold, respectively. In the control S9 fraction, the number of
His revertants was increased at 1.5, 3.8, and 7.5 M/plate,0
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FIG. 1. Increasing doses of BaP (M/plate) were assayed with 10
bacteria (TA 98) and 50 L of liver S9. Assays without S9 (!S9) were
included as controls. Data indicate the total number of His revertants per
plate, plotted as mean$SE of two replicates of three independent experi-
ments. S9I, S9 fraction BNF-induced; S9NI, S9 fraction noninduced.demonstrating as 2.5-, 2.8-, and 3.6-fold BaP activation,
respectively. When BaP was tested without the metabolic
activator (S9), the number of His revertants became very
low, and were classi"ed as spontaneous revertants.
Regarding BNF activation (Fig. 2 and Table 2) by BNF-
induced liver S9, an increase (2.33-fold) in His revertants
at 11.1 nM BNF was observed. Control liver S9 did not
demonstrate any BNF activation, for any BNF concentra-
tion tested.BaP
(M/plate) S9I S9NI !S9
0 46$3 (1.0) 45$3 (1.0) 45$3 (1.0)
0.015 73$2 (1.6) 66$5 (1.5) 64$4 (1.4)
0.08 79$5 (1.7) 73$5 (1.6) 70$6 (1.6)
0.15 88$6 (1.9) 75$3 (1.7) 77$7 (1.8)
0.38 103$4 (2.2) 79$3 (1.8) 79$8 (1.8)
0.75 129$15 (2.8) 87$3 (1.9) 78$8 (1.7)
1.5 145$19 (3.2) 111$5 (2.8) 82$7 (1.8)
3.8 166$23 (3.6) 128$8 (2.8) 89$9 (1.9)
7.5 198$25 (4.3) 161$21 (3.6) 89$8 (1.9)
Note. Assays without S9 (!S9) were included as controls. Data indicate
the total number of His revertants per plate, plotted as mean$SE of two
replicates of three independent experiments.
Liver S9 isolated from A. anguilla L. at 8 h exposure to 0.3 M BNF.
Liver S9 isolated from A. anguilla L. at 8 h exposure to clean water
(Control).
The ratio BaP concentration versus blank revertants (without BaP,
spontaneous revertants).
P(0.01 compared to control (!S9).
P(0.02.
TABLE 2
-Naphtho6avone Mutagenic Activation
by Anguilla anguilla L. Liver S9 Fraction
#S9
BNF
(M/plate) S9I S9NI !S9
0 54$1 (1.0) 53$1 (1.0) 51$2 (1.0)
0.412 73$4 (1.4) 66$2 (1.5) 64$2 (1.3)
1.24 74$2 (1.4) 69$1 (1.3) 66$1 (1.3)
3.7 93$4 (1.7) 74$2 (1.4) 67$1 (1.3)
11.1 126$2 (2.3) 86$1 (1.6) 84$2 (1.7)
33 91$4 (1.7) 71$1 (1.4) 71$3 (1.4)
100 79$3 (1.5) 69$1 (1.4) 60$2 (1.2)
Note. Assays without S9 (!S9) were included as controls. Data indicate
the total number of His revertants per plate, plotted as mean$SE of two
replicates of three independent experiments.
Liver S9 isolated from A. anguilla L. at 8 h exposure to 0.3 M BNF.
Liver S9 isolated from A. anguilla L. at 8 h exposure to clean water
(Control).
The ratio BaP concentration Versus blank revertants (without BNF,
spontaneous revertants).
P(0.01 compared to control.
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Metabolic activation of known promutagens can be
easily carried out with bacterial genotoxicity assays.
Promutagen in vitro activation by the mammalian S9 seems
to be closely related to the in vivo Phase I biotransformation
pathways without a convenient and e!ective Phase II. How-
ever, promutagen metabolic activation by "sh S9 fractions
has not been extensively studied (RodrmHguez-Ariza
et al., 1994).
According to the current results (Fig. 1 and Table 1), eel
S9 liver fractions have the ability to promote biotransforma-
tion of the highest BaP doses into reactive metabolites
which induce a His reversion in Salmonella TA98 strain.
However, the presence of the S9 fraction induced by BNF
seems to increase the mutagenic e!ects of BaP doses ranging
from 0.38 up to 7.5 M/plate, since the number of revertants
was higher than those found with control liver S9. A
dose-related mutagenic response was also found as a His
reversion in Salmonella TA98 strain at a BaP concentration
range between 1.5 and 7.5 M/plate for control liver S9. In
the absenceA. anguilla L. S9, the TA 98 strain did not revert.
This is due to the fact that BaP requires metabolic activa-
tion for its biotransformation and cofactors in the medium,
such as glucose-6-phosphate and NADP, which promote
NADPH generation. The results suggest that an increase of
BaP mutagenic activity in eel BNF-induced liver S9 frac-
tion, at 0.38, 0.75, 1.5, 3.8, and 7.5 M/plate BaP dose levels,
is due to the excessive production of BaP reactive metab-
olites as well as to its lack of conjugation. One possibleexplanation may be the suppression of a Phase II reaction
in vitro when there is a high concentration of substrate
interacting with the monooxygenase-dependent P450 sys-
tem. However, at the lowest BaP concentration range,
0.015}0.08 M/plate, no mutagenic activity was observed
for BNF-induced S9 or for noninduced S9.
Previous research has reported that the use of hepatic
microsomes from BNF-treated mice as an enzyme source in
mutagenicity tests produced marked increases in the activa-
tion of BaP to mutagenic products (Raina et al., 1985).
The assessment of the BNF mutagenic potential (Fig. 2
and Table 2) with BNF-induced S9 fraction revealed
that the 11.1 nM BNF concentration promoted the appear-
ance of His S. typhimurium TA98 (2.33-fold), whereas
concentrations lower and higher than 11.1 nM did not
induce mutagenic activity. Furthermore, it was also
observed that for the two highest concentrations, 33 and
100 nM BNF, there was a decrease in the number of the
revertants, 1.7- and 1.5-fold, respectively. In the S9 control
fraction, the mutagenic e!ect of BNF was not observed.
Using cytochrome P-4501A as an indicator (Goksoyr and
Forlin, 1992), the e!ects of BNF biotransformation induc-
tion on Sparus aurata and ¸iza aurata were analyzed by
Cousinou et al. (2000). They observed an increase in EROD
activity (9.1- and 3.7-fold higher than controls, respectively).
These authors also observed BNF biotransformation induc-
tion in S. aurata and ¸. aurata resulting from the ability of
the S9 liver fraction to convert 2-aminoanthracene (2-AA)
into mutagens, which were detectable by the S. typhimurium
strain BA149. In the BNF-treated "sh the activation of
2-AA into genotoxins was dramatically increased compared
to controls.
CONCLUSIONS
From the current study, the following conclusions are
made: (1) A. anguilla L. liver S9 has the capacity to convert
a promutagen such as BaP into a mutagenic compound. (2).
A. anguilla L. liver S9 induced by BNF is required to
convert very low concentrations of a promutagen such as
BaP into a mutagenic compound. The results suggest that
previous liver EROD induction is required for low concen-
trations of promutagens to be converted into mutagenic
compounds. The results concerning BNF seem inconclusive,
since low concentrations have no mutagenic e!ect, high
concentrations are inhibitory, and an intermediate concen-
tration is mutagenic.
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